-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – (Dextromethorphan + Quinidine Sulfate) in Migraine
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Dextromethorphan + Quinidine Sulfate) in Migraine report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Dextromethorphan + Quinidine Sulfate) in Migraine Drug Details: Dextromethorphan hydrobromide...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – (Dextromethorphan + Quinidine Sulfate) in Treatment Resistant Depression
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (Dextromethorphan + Quinidine Sulfate) in Treatment Resistant Depression report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (Dextromethorphan + Quinidine Sulfate) in Treatment Resistant Depression...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Dextromethorphan in Pseudobulbar Affect (PBA)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.Dextromethorphan in Pseudobulbar Affect (PBA)Drug Details:Dextromethorphan (MR-201) is under development for the treatment of pseudobulbar affect...
-
Product Insights
PBA Land – Canadian Commercial Center Renovation – Alberta
Equip yourself with the essential tools needed to make informed and profitable decisions with our PBA Land - Canadian Commercial Center Renovation - Alberta report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep into...
-
Product Insights
PBA Immo/ PEG HH – Schnelsen 95 Residential Building – Hamburg
Equip yourself with the essential tools needed to make informed and profitable decisions with our PBA Immo/ PEG HH - Schnelsen 95 Residential Building - Hamburg report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive...
-
Product Insights
Otto Wulff Bauunternehmung/ PBA Immo/ PEG HH – Bahrenfeld Emils Quartier Residential Complex – Hamburg
Equip yourself with the essential tools needed to make informed and profitable decisions with our Otto Wulff Bauunternehmung/ PBA Immo/ PEG HH - Bahrenfeld Emils Quartier Residential Complex - Hamburg report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash...
-
Company Profile
Avanir Pharmaceuticals Inc – Company Profile
Avanir Pharmaceuticals Inc (Avanir), a subsidiary of Otsuka Pharmaceutical Co Ltd. is a biopharmaceutical company that focuses on the research, development, and commercialization of medical and pharmaceutical treatments for central nervous system disorders. The company’s lead product include Nuedexta, a medication used for the treatment of pseudobulbar affect (PBA). The company's pipeline product include AVP-786 intended for the treatment of agitation in Alzheimer’s disease, residual schizophrenia, intermittent explosive disorder, disinhibition in dementia and traumatic brain injury behavioral dysfunction, among others....
Add to Basket -
Product Insights
PBA Land – Calgary 17 Select Mixed-Use Development – Alberta
Equip yourself with the essential tools needed to make informed and profitable decisions with our PBA Land - Calgary 17 Select Mixed-Use Development - Alberta report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
Net Present Value Model: Nuedexta
Overview Evaluating the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the market currently and in the future, knowledge of cash inflows and outflows and the potential success rates for each stage of drug development. GlobalData has done all of this work for you, leveraging its gold standard Drugs Intelligence database to create high-value NPV models for purchase on a drug-by-drug basis. Drug Operating Profit Model Nuedexta Drug Details Dextromethorphan hydrobromide and...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – dextromethorphan
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry dextromethorphan Drug Details Dextromethorphan (MR-201) is under development for the treatment of pseudobulbar affect...